Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) (344139)

    From US Department of Health & Human Services: National Institutes of Health (NIH)

    The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

    Type of Support

    Overview

    The Avenir Award supports early-stage investigators embarking on highly innovative studies. It focuses on aiding those at the beginning of their careers who may not have the preliminary data for an R01 grant but propose impactful research and demonstrate potential as future leaders. NIDA has initiated two Avenir Award Programs for research in HIV/AIDS and in genetics or epigenetics. Each application may request up to $300,000 in Direct Costs annually for a maximum of five years, in addition to applicable Facilities and Administrative (F&A) costs.

    Eligibility

    Organization's Location
    aute pariatur
    Program Location
    nostrud
    Organization Type

    Submission

    Schedule
    Step 1: aliquip fugiat veniam
    Step 2: ut laborum (sit cupidatat)